SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 75 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $32,000 | -20.0% | 4,352 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $40,000 | +73.9% | 4,352 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | 0.0% | 4,352 | -16.3% | 0.00% | -100.0% |
| Q4 2018 | $23,000 | -94.3% | 5,202 | -91.0% | 0.00% | -88.9% |
| Q2 2018 | $406,000 | -67.9% | 57,868 | -47.4% | 0.01% | -35.7% |
| Q1 2018 | $1,264,000 | +162.2% | 109,956 | +100.0% | 0.01% | +40.0% |
| Q4 2017 | $482,000 | -32.5% | 54,978 | -10.0% | 0.01% | -41.2% |
| Q3 2017 | $714,000 | -10.6% | 61,064 | +6.7% | 0.02% | -10.5% |
| Q2 2017 | $799,000 | +68.6% | 57,222 | +65.8% | 0.02% | +72.7% |
| Q1 2017 | $474,000 | +91.9% | 34,510 | 0.0% | 0.01% | +83.3% |
| Q4 2016 | $247,000 | – | 34,510 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |